AAV2-Retro Reference-2.8kb

The AAV2-Retro reference-2.8kb material contains a 2.8kb AAV-CMV-SV40I-EGFP-WPRE-hGHpolyA genome in AAV2-Retro capsid, with a genome titer (EGFP targeting) of 1X10^13 VG/ml. This reference is produced using the AAVone system with the pAAVone-AAV2-Retro-CMV-EGFP-2.8kb plasmid. AAV2-Retro (often referred to simply as AAV-Retro) is a modified version of the AAV2 serotype that was engineered to efficiently transduce neurons and other cells in a retrograde manner. This means that AAV2-Retro can travel from the axon terminals of neurons back to their cell bodies, enabling highly efficient gene delivery across neural circuits. It was developed to overcome the limitations of traditional AAV serotypes that are less efficient at crossing synapses and spreading through neural networks.

Please contact us at for specific academic pricing.

Background

AAV references are crucial for qPCR-based vector genome quantification and fundamental for ensuring accuracy in viral vector research and gene therapy development. Our AAV reference materials undergo extensive characterization, including full ratio (mass photometry), genome titer (ddPCR), capsid titer (ELISA), purity (SDS-PAGE silver staining), and tests for bioburden, endotoxin, and mycoplasma. Quantification is based on reference material from ATCC. These thoroughly analyzed particles provide precise genome titers, well-defined full-to-empty capsid ratios, and accurate capsid titers. This comprehensive characterization is essential for standardizing measurements, ensuring consistency across experiments, and delivering reliable data for gene therapy applications and other research involving AAV vectors.
AAV references (Truly-Empty) are produced by transfection of a single mini-pHelper-AAV plasmid with the corresponding serotypes. AAV references (Full) and AAV references (Byproduct-Empty) are generated using the AAVone system, with the corresponding pAAVone plasmids carrying AAV-CMV-SV40I-EGFP-WRRE-hGHpolyA genomes.